Information presented is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed
The medication has a long half-life that provides consistent blood levels throughout the week regardless of injection time
After 84 weeks, tirzepatide participants lost an average of 26.6%, while those on the highest dose of retatrutide lost around 24.2% over 48 weeks
Research shows that a notable proportion of weight lost during GLP-1 treatment can come from lean body mass rather than fat alone - depending on the medication, individual factors, and whether resistance training was maintained during treatment
Comparisons with Injectable Forms While Rybelsus has shown efficacy, some studies suggest that injectable GLP-1 medications may offer superior results in terms of weight loss and blood sugar control
Despite all the changes, it seems likely that compounding pharmacies will continue to offer GLP-1 drugs, at least for the foreseeable future, says Brunner: Some patients will be able to maintain these therapies at a price point they can afford in a customized formulation. The Takeaway The FDA ordered compounding pharmacies to stop producing and selling copies of GLP-1 injectable drugs like Ozempic, Wegovy, Mounjaro, and Zepbound, as official shortages have ended
